A share price of Clearside Biomedical Inc [CLSD] is currently trading at $0.4, down -5.61%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CLSD shares have lost -7.37% over the last week, with a monthly amount glided 18.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Clearside Biomedical Inc [NASDAQ: CLSD] stock has seen the most recent analyst activity on July 18, 2025, when Stifel downgraded its rating to a Hold but kept the price target unchanged to $2 for it. Previously, H.C. Wainwright downgraded its rating to Neutral on July 18, 2025. On July 18, 2025, downgrade downgraded it’s rating to Neutral. Chardan Capital Markets started tracking the stock assigning a Buy rating and suggested a price target of $6 on August 21, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $5 as its price target on June 25, 2024. In a note dated July 29, 2021, H.C. Wainwright initiated a Buy rating and provided a target price of $10 on this stock.
Clearside Biomedical Inc experienced fluctuations in its stock price throughout the past year between $0.29 and $1.65. Clearside Biomedical Inc [NASDAQ: CLSD] shares were valued at $0.4 at the most recent close of the market.
Analyzing the CLSD fundamentals
Trailing Twelve Months sales for Clearside Biomedical Inc [NASDAQ:CLSD] were 4.17M which represents 446.67% growth. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -5.25%, Pretax Profit Margin comes in at -6.48%, and Net Profit Margin reading is -6.65%. To continue investigating profitability, this company’s Return on Assets is posted at -1.81, Equity is 0.66 and Total Capital is -1.78. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3823 points at the first support level, and at 0.3627 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4303, and for the 2nd resistance point, it is at 0.4587.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Clearside Biomedical Inc [NASDAQ:CLSD] is 3.87. As well, the Quick Ratio is 3.87, while the Cash Ratio is 3.08. Considering the valuation of this stock, the price to sales ratio is 7.57.
Transactions by insiders
Recent insider trading involved Thorp Clay, Director, that happened on Feb 24 ’25 when 15000.0 shares were purchased. Chief Medical Officer, Chong Ngai Hang Victor completed a deal on Nov 01 ’24 to buy 36500.0 shares.
